Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile.
Open | $3.89 |
Close | $3.77 |
Volume / Avg. | 5.77M / 1.88M |
Day Range | $3.67 - $3.89 |
52 Wk Range | 3.40 - 11.69 |
Market Cap | $307.71M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 27.66% |
Days to Cover | 12.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
There is no analysis for Editas Medicine to provide a consensus price target.
The stock price for Editas Medicine (NASDAQ: EDIT) is $3.7309 last updated September 20, 2024 at 7:44 PM EDT.
There are no upcoming dividends for Editas Medicine.
Editas Medicine does not have any upcoming earnings scheduled.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.